Objective. To study the immediate and remote results of treatment in patients with rectal fistulas, in whom Gabriel operation, Maslyak operation, and the ligature method were applied, as well as to create optimal indications to every kind of surgical intervention. Materials and methods. Results of treatment of 50 patients, suffering rectal fistulas, were analyzed. In 6 (12.0%) patients with intersphincteric and in 26 (52.0%) with transsphincteric fistulas Gabriel operation was performed, in 9 (18.0%) patients with transsphincteric and in 5 (10.0%) with extrasphincteric fistulas – Maslyak operation. In 2 (4.0%) patients with transsphincteric and in 2(4.0%) with extrasphincteric fistulas the ligature method was applied. Results. In 6 mo after Gabriel operation the anal sphincter insufficiency was noted in 2 (6.2%) patients with transsphincteric fistulas. Fistula’s recurrence have had occurred in 1 (7.1%) patient after Maslyak operation. Good remote results were obtained in all patients, operated with application of the ligature method. Conclusion. There was established, that Gabriel operation results are the best for intrasphincteric fistulas. In transsphincteric fistulas application of this operation must be restricted. Maslyak operation and the ligature method are rather effective in transsphincteric and extrasphincteric fistulas – 92.9 and 100.0% good results accordingly.
From year to year, wide spread of gastroesophageal reflux disease (GERD) is attracting greater attention of specialists in the field of this pathology diagnosis and treatment. In-depth studies on etiological and pathogenetic factors in the GERD development are being conducted. Of particular interest is the role of humoral factors, one of which is vasoactive intestinal peptide (VIP). There are currently no data on the dynamics of this hormone during surgical treatment of GERD. The aim of the study was to examine the dynamics of plasma VIP during surgical treatment of GERD and its influence on the lower esophageal sphincter (LES) function. Materials and methods. Surgical treatment in the Nissen modification was performed for 35 patients with GERD. There were 26 women (74.3 %), men – 9 (25.7 %). mean age – 55.3 ± 11.3 years. Comparison group – 20 apparently healthy individuals: women – 14 (70.0 %); men – 6 (30.0 %), mean age – 56.7 ± 10.6 years. VIP was measured in venous blood plasma by an enzyme immunoassay (Vasoactive intestinal peptide ELISA, S-1201, BCM Diagnostics) using an immunoenzyme complex ImmunoChem-2100 (USA). The sampling of the studied samples in the main group was carried out before the operation and 2–3 months post-surgery. Results. In the main group before the surgery, the level of VIP was 3.1 ± 1.1 ng/ml, after the surgery – 2.2 ± 1.0 ng/ml. In the comparison group, VIP was determined at the level of 2.1 ± 1.1 ng/ml. In GERD before the surgery, the VIP level was statistically different from the indicators in the comparison group and from postoperative values. After surgical treatment, VIP values were decreased to the level of apparently healthy individuals. There was a positive correlation between the VIP level and acid exposure time (AET), the total number of refluxes, the number of reflux events longer than 5 minutes, the maximum duration of refluxes and the degree of esophageal inflammation. Conclusions. In the surgical treatment of GERD, the statistically significant decrease in the VIP level to that of apparently healthy individuals is determined. The moderate positive correlation between the levels of VIP, AET, the average number of refluxes, the number of reflux events longer than 5 minutes, and the maximum duration of refluxes confirms the inhibitory effect of VIP on LES tone. The relationship between the degree of esophageal inflammation and the VIP level confirms the indirect, through the action of VIP, inhibitory effect of the esophagitis severity on the LES tone.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.